PUBLISHER: KBV Research | PRODUCT CODE: 1635249
PUBLISHER: KBV Research | PRODUCT CODE: 1635249
LAMEA Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type (Wearable, Mobile based Applications, Sensors, and Other Type), By Clinical Practice, By End Use, By Country and Growth Forecast, 2024 - 2031
The Latin America, Middle East and Africa Psychiatric Digital Biomarkers Market would witness market growth of 26.4% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Psychiatric Digital Biomarkers Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $50 million by 2031. The Argentina market is expected to witness a CAGR of 27.4% during (2024 - 2031). Additionally, The UAE market is expected to witness a CAGR of 25.3% during (2024 - 2031).
Virtual care platforms and wearable devices further enhance the integration of psychiatric digital biomarkers. Telehealth services use data from wearables, such as physiological metrics and behavioral patterns, to support remote mental health monitoring and informed treatment decisions. Wearables provide real-time insights into mental health conditions, allowing for proactive interventions. Together, these components of the digital health ecosystem create a robust framework for improving mental health care, making it more inclusive, precise, and accessible for diverse populations.
The growing aging population is significantly impacting the prevalence of age-related psychiatric conditions, necessitating the development of innovative diagnostic tools and solutions. As life expectancy increases worldwide, so does the number of older adults, many of whom are at heightened risk for mental health disorders, including dementia, depression, and anxiety.
In South America, the Pan American Health Organization (PAHO) highlights the profound impact of mental, neurological, substance use disorders, and suicide (MNSS) in Brazil. These conditions account for 19% of all disability-adjusted life years (DALYs) and 38% of all years lived with disability (YLDs) in the country. Mental and behavioral problems are the third leading cause of sick leave, comprising 52% of all social benefits disbursed between 2007 and 2017. Mood disorders alone represent around half of these claims. As of October 2020, an estimated 65,453 employees were on temporary leave due to mental illness, constituting approximately 8% of all paid sick leave benefits. Additionally, 284,292 Brazilians are retired due to mental health conditions, reflecting the long-term socioeconomic impact of these disorders. Therefore, these challenges underscore the urgent need for innovative psychiatric digital biomarkers to facilitate early detection, monitoring, and intervention for mental health conditions in the LAMEA region.
Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors, and Other Type. Based on Clinical Practice, the market is segmented into Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, and Other Clinical Practice. Based on End Use, the market is segmented into Healthcare Companies, Healthcare Providers, Payers, and Other End Use. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Canary Speech, Inc
- Sonde Health, Inc. (Puretech Health Plc)
- Koneksa Health Inc.
- Empatica Inc.
- VivoSense, Inc.
- IXICO Plc
- Neurotrack Technologies, Inc.
- Winterlight Labs
- Aural Analytics, Inc. (Linus Health)
LAMEA Psychiatric Digital Biomarkers Market Report Segmentation
By Type
- Wearable
- Mobile based Applications
- Sensors
- Other Type
By Clinical Practice
- Diagnostic Psychiatric Digital Biomarkers
- Monitoring Psychiatric Digital Biomarkers
- Predictive and Prognostic Psychiatric Digital Biomarkers
- Other Clinical Practice
By End Use
- Healthcare Companies
- Healthcare Providers
- Payers
- Other End Use
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Psychiatric Digital Biomarkers Market, by Type
- 1.4.2 LAMEA Psychiatric Digital Biomarkers Market, by Clinical Practice
- 1.4.3 LAMEA Psychiatric Digital Biomarkers Market, by End Use
- 1.4.4 LAMEA Psychiatric Digital Biomarkers Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Psychiatric Digital Biomarkers Market by Type
- 4.1 LAMEA Wearable Market by Country
- 4.2 LAMEA Mobile based Applications Market by Country
- 4.3 LAMEA Sensors Market by Country
- 4.4 LAMEA Other Type Market by Country
Chapter 5. LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice
- 5.1 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country
- 5.2 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country
- 5.3 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country
- 5.4 LAMEA Other Clinical Practice Market by Country
Chapter 6. LAMEA Psychiatric Digital Biomarkers Market by End Use
- 6.1 LAMEA Healthcare Companies Market by Country
- 6.2 LAMEA Healthcare Providers Market by Country
- 6.3 LAMEA Payers Market by Country
- 6.4 LAMEA Other End Use Market by Country
Chapter 7. LAMEA Psychiatric Digital Biomarkers Market by Country
- 7.1 Brazil Psychiatric Digital Biomarkers Market
- 7.1.1 Brazil Psychiatric Digital Biomarkers Market by Type
- 7.1.2 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.1.3 Brazil Psychiatric Digital Biomarkers Market by End Use
- 7.2 Argentina Psychiatric Digital Biomarkers Market
- 7.2.1 Argentina Psychiatric Digital Biomarkers Market by Type
- 7.2.2 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.2.3 Argentina Psychiatric Digital Biomarkers Market by End Use
- 7.3 UAE Psychiatric Digital Biomarkers Market
- 7.3.1 UAE Psychiatric Digital Biomarkers Market by Type
- 7.3.2 UAE Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.3.3 UAE Psychiatric Digital Biomarkers Market by End Use
- 7.4 Saudi Arabia Psychiatric Digital Biomarkers Market
- 7.4.1 Saudi Arabia Psychiatric Digital Biomarkers Market by Type
- 7.4.2 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.4.3 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use
- 7.5 South Africa Psychiatric Digital Biomarkers Market
- 7.5.1 South Africa Psychiatric Digital Biomarkers Market by Type
- 7.5.2 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.5.3 South Africa Psychiatric Digital Biomarkers Market by End Use
- 7.6 Nigeria Psychiatric Digital Biomarkers Market
- 7.6.1 Nigeria Psychiatric Digital Biomarkers Market by Type
- 7.6.2 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.6.3 Nigeria Psychiatric Digital Biomarkers Market by End Use
- 7.7 Rest of LAMEA Psychiatric Digital Biomarkers Market
- 7.7.1 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type
- 7.7.2 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice
- 7.7.3 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use
Chapter 8. Company Profiles
- 8.1 Canary Speech, Inc.
- 8.1.1 Company Overview
- 8.1.2 SWOT Analysis
- 8.2 Sonde Health, Inc. (Puretech Health Plc)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Research & Development Expenses
- 8.2.4 Recent strategies and developments:
- 8.2.4.1 Partnerships, Collaborations, and Agreements:
- 8.2.4.2 Product Launches and Product Expansions:
- 8.2.5 SWOT Analysis
- 8.3 Koneksa Health Inc.
- 8.3.1 Company Overview
- 8.4 Empatica Inc.
- 8.4.1 Company Overview
- 8.5 VivoSense, Inc.
- 8.5.1 Company Overview
- 8.6 IXICO plc
- 8.6.1 Company Overview
- 8.7 Neurotrack Technologies, Inc.
- 8.7.1 Company Overview
- 8.8 WinterLight Labs
- 8.8.1 Company Overview
- 8.9 Aural Analytics, Inc. (Linus Health)
- 8.9.1 Company Overview
LIST OF TABLES
- TABLE 1 LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 2 LAMEA Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 3 LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 4 LAMEA Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 5 LAMEA Wearable Market by Country, 2020 - 2023, USD Million
- TABLE 6 LAMEA Wearable Market by Country, 2024 - 2031, USD Million
- TABLE 7 LAMEA Mobile based Applications Market by Country, 2020 - 2023, USD Million
- TABLE 8 LAMEA Mobile based Applications Market by Country, 2024 - 2031, USD Million
- TABLE 9 LAMEA Sensors Market by Country, 2020 - 2023, USD Million
- TABLE 10 LAMEA Sensors Market by Country, 2024 - 2031, USD Million
- TABLE 11 LAMEA Other Type Market by Country, 2020 - 2023, USD Million
- TABLE 12 LAMEA Other Type Market by Country, 2024 - 2031, USD Million
- TABLE 13 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 14 LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 15 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 16 LAMEA Diagnostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 17 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 18 LAMEA Monitoring Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 19 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 20 LAMEA Predictive and Prognostic Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 21 LAMEA Other Clinical Practice Market by Country, 2020 - 2023, USD Million
- TABLE 22 LAMEA Other Clinical Practice Market by Country, 2024 - 2031, USD Million
- TABLE 23 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 24 LAMEA Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 25 LAMEA Healthcare Companies Market by Country, 2020 - 2023, USD Million
- TABLE 26 LAMEA Healthcare Companies Market by Country, 2024 - 2031, USD Million
- TABLE 27 LAMEA Healthcare Providers Market by Country, 2020 - 2023, USD Million
- TABLE 28 LAMEA Healthcare Providers Market by Country, 2024 - 2031, USD Million
- TABLE 29 LAMEA Payers Market by Country, 2020 - 2023, USD Million
- TABLE 30 LAMEA Payers Market by Country, 2024 - 2031, USD Million
- TABLE 31 LAMEA Other End Use Market by Country, 2020 - 2023, USD Million
- TABLE 32 LAMEA Other End Use Market by Country, 2024 - 2031, USD Million
- TABLE 33 LAMEA Psychiatric Digital Biomarkers Market by Country, 2020 - 2023, USD Million
- TABLE 34 LAMEA Psychiatric Digital Biomarkers Market by Country, 2024 - 2031, USD Million
- TABLE 35 Brazil Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 36 Brazil Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 37 Brazil Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 38 Brazil Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 39 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 40 Brazil Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 41 Brazil Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 42 Brazil Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 43 Argentina Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 44 Argentina Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 45 Argentina Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 46 Argentina Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 47 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 48 Argentina Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 49 Argentina Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 50 Argentina Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 51 UAE Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 52 UAE Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 53 UAE Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 54 UAE Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 55 UAE Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 56 UAE Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 57 UAE Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 58 UAE Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 59 Saudi Arabia Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 60 Saudi Arabia Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 61 Saudi Arabia Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 62 Saudi Arabia Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 63 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 64 Saudi Arabia Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 65 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 66 Saudi Arabia Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 67 South Africa Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 68 South Africa Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 69 South Africa Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 70 South Africa Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 71 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 72 South Africa Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 73 South Africa Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 74 South Africa Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 75 Nigeria Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 76 Nigeria Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 77 Nigeria Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 78 Nigeria Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 79 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 80 Nigeria Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 81 Nigeria Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 82 Nigeria Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 83 Rest of LAMEA Psychiatric Digital Biomarkers Market, 2020 - 2023, USD Million
- TABLE 84 Rest of LAMEA Psychiatric Digital Biomarkers Market, 2024 - 2031, USD Million
- TABLE 85 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type, 2020 - 2023, USD Million
- TABLE 86 Rest of LAMEA Psychiatric Digital Biomarkers Market by Type, 2024 - 2031, USD Million
- TABLE 87 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2020 - 2023, USD Million
- TABLE 88 Rest of LAMEA Psychiatric Digital Biomarkers Market by Clinical Practice, 2024 - 2031, USD Million
- TABLE 89 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use, 2020 - 2023, USD Million
- TABLE 90 Rest of LAMEA Psychiatric Digital Biomarkers Market by End Use, 2024 - 2031, USD Million
- TABLE 91 Key Information - Canary Speech, Inc.
- TABLE 92 Key Information - Sonde Health, Inc.
- TABLE 93 Key Information - Koneksa Health Inc.
- TABLE 94 Key Information - Empatica Inc.
- TABLE 95 Key Information - VivoSense, Inc.
- TABLE 96 Key Information - IXICO plc
- TABLE 97 Key Information - Neurotrack Technologies, Inc.
- TABLE 98 Key Information - WinterLight Labs
- TABLE 99 Key Information - Aural Analytics, Inc.
